Upgrade to SI Premium - Free Trial

Galectin Therapeutics (GALT)

3.45 -0.05 (1.43%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 GALECTIN THERAPEUTICS For: Jul 14 Filed by: Jamil Khurram July 16, 2026 5:40 PM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jun 26 Filed by: Shlevin Harold H. June 30, 2026 7:24 PM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jun 26 Filed by: Jamil Khurram June 30, 2026 7:23 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Shlevin Harold H. June 29, 2026 4:10 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Jamil Khurram June 26, 2026 6:09 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Shlevin Harold H. June 26, 2026 4:16 PM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: Jun 23 Filed by: Jamil Khurram June 25, 2026 4:06 PM - SEC Filing Form 144 GALECTIN THERAPEUTICS Filed by: Jamil Khurram June 23, 2026 4:15 PM - SEC Filing Galectin reaches FDA agreement on belapectin Phase 3 trial design June 23, 2026 8:00 AM - StreetInsider Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension June 23, 2026 8:00 AM - Globe NewsWire Form 8-K GALECTIN THERAPEUTICS For: Jun 23 June 23, 2026 7:51 AM - SEC Filing Form 4 GALECTIN THERAPEUTICS For: May 26 Filed by: Jamil Khurram May 28, 2026 9:13 AM - SEC Filing Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis May 27, 2026 8:00 AM - Globe NewsWire Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update May 15, 2026 8:00 AM - Globe NewsWire Form 8-K GALECTIN THERAPEUTICS For: May 15 May 15, 2026 7:51 AM - SEC Filing Form 10-Q GALECTIN THERAPEUTICS For: Mar 31 May 15, 2026 7:46 AM - SEC Filing Galectin Therapeutics publishes belapectin trial results in Hepatology May 11, 2026 8:00 AM - StreetInsider Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology May 11, 2026 8:00 AM - Globe NewsWire Full Article List